Navigation Links
Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
Date:4/15/2008

Combination Treatment with an Optimized Antiretroviral Therapy Regimen in HIV-Infected Treatment-Experienced Subjects), evaluate the virologic benefit of adding vicriviroc 30 mg once daily to an optimized ritonavir-boosted PI-containing background therapy compared to a control group receiving new optimized background therapy alone. The optimized background therapy must include at least two drugs to which the patient's HIV is susceptible. Patients coinfected with hepatitis B or C may be included in these studies and there are no exclusions of commonly prescribed drugs or need for dose adjustments based on the known vicriviroc drug-drug interaction profile. The two studies are currently enrolling approximately 375 patients each at more than 160 sites in North America, Latin America, Europe, Australia and South Africa.

For more information about vicriviroc clinical studies, please visit http://www.clinicaltrials.gov, search term: vicriviroc.

About Schering-Plough

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
2. Schering-Plough Reports Top-Line Results of the IDEAL Study
3. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
4. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
5. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
6. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
7. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
8. Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer
9. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
10. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
11. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , June 30, 2015 ... ) has announced the addition of the ... report to their offering. This ... biomedicine. Photoacoustic imaging is a safe, non-invasive, ... advantages and represents a great alternative to ...
(Date:7/7/2015)... VIEJO, Calif. , July 7, 2015 /PRNewswire/ ... company focused on developing innovative devices for the ... R. Michael Kleine has joined its Board ... over 25 years of medical device and healthcare ... biomedical companies where he has commercialized numerous leading-edge ...
(Date:7/7/2015)... Accelovance, Inc. (Accelovance), a global contract ... General Medicine announced the completion of enrollment and ... Therapeutics, Inc. for the Phase 3 trial of ... SUSTOL® (granisetron injection, extended release) as part of ... receptor antagonist fosaprepitant and IV corticosteroid dexamethasone ...
Breaking Medicine Technology:Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... a subsidiary of Kyowa Hakko Kirin Co. Ltd. (KHK), ... the U.S. Food and Drug Administration (FDA) has approved ... and Mitigation Strategy) Access program. This new REMS is ... ABSTRAL ® (fentanyl) sublingual tablets, an ...
... 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. ... pharmaceutical company that specializes in patented biopharmaceutical ... and active pharmaceutical ingredients (API) today announced ... Chengdu Tianyin Pharmaceutical Co., Ltd,s ("Chengdu Tianyin") ...
Cached Medicine Technology:FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 2FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 3FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 4FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 5FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 6TPI Receives Approval for High Tech Enterprise Status 2
(Date:7/7/2015)... ... July 07, 2015 , ... Dr. Poneh Ghasri , ... treatments. A professional teeth whitening is one of the fastest, easiest ways to brighten ... they can decrease smile satisfaction and confidence. With the right teeth whitening treatment, patients ...
(Date:7/7/2015)... San Mateo, CA (PRWEB) , ... July 07, 2015 , ... ... and inspire others. California Casualty’s Nominate A Hero program offers a special ... Each month a well-deserving hero receives a $250 gift card and their place on ...
(Date:7/7/2015)... ... July 07, 2015 , ... Office ... the company’s new Chief Financial Officer, effective July 6th, 2015. Ellen joins Office ... ranging from a multi-billion dollar, global chemical company to early and growth-stage technology ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... highly educated and motivated leaders with strong managerial expertise to oversee large ... communicate with patients, staff, providers, business partners, insurance companies, and regulators. American ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... management solutions, has announced the release of Service Pack 5600 for its ... a number of enhancements to the already robust capabilities of the reporting ...
Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3Health News:California Casualty Wants to Know: "Who Is Your Hero?" 2Health News:Office Practicum Announces new CFO 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2
... Maureen Salamon HealthDay Reporter , THURSDAY, Sept. 29 ... every corner of the globe, new research suggests that folks ... the workday progresses, regardless of where they live. The ... of 2.4 million people in 84 countries over two years, ...
... FRIDAY, Sept. 30 (HealthDay News) -- Unspoken clues -- ... according to a new study. Researchers from the University ... an impact on how patients view their relationship with ... The findings could help doctors better understand how they ...
... Franklin was right, at least on the healthy part. "Early to ... of early-bird Australian youths keep slimmer and more physically active than ... of sleep. A study in the Oct. 1 issue of ... of 2,200 Australian participants, ages 9 to 16, and compared their ...
... Picky eating is normal in children, but a pediatric feeding ... a child,s physical and mental development, an expert says. ... clinical director of the Pediatric Feeding Disorders Program at the ... reject certain foods but still has a nourishing diet. Children ...
... , THURSDAY, Sept. 29 (HealthDay News) --,New ... in a large-scale analysis of genetic data related to ... Philadelphia examined six large databases for DNA data from ... healthy people. In addition to validating results from ...
... LOS ANGELES (Sept. 29, 2011) Six leaders in ... will be key presenters at the world,s largest interdisciplinary ... The World Stem Cell Summit, co-sponsored by the ... the global stem cell and regenerative medicine community. ...
Cached Medicine News:Health News:Twitter Reflects World's Changing Moods 2Health News:Twitter Reflects World's Changing Moods 3Health News:Doctors Consider Nonverbal Cues in Medical Decisions 2Health News:Early to bed and early to rise -- study suggests it's keeping kids leaner 2Health News:Does Your Picky Eater Have a 'Feeding Disorder'? 2Health News:Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit 2Health News:Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit 3
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
New - Color Coded Berman Airways. A simple idea makes size identification easier for you., ,Premium upgrade without a premium price. Color Coded Berman airways are latex-free., ,Plastic. Single use...
... uncuffed endotracheal tubes are available ... in standard or precut lengths., ... pediatric uncuffed endotracheal tubes are ... with a radiopaque blue line ...
... Line® uncuffed endotracheal tubes are ... styles, in standard or precut ... and pediatric uncuffed endotracheal tubes ... chloride with a radiopaque blue ...
Medicine Products: